2021年 業績一覧

  1. Yonezawa Y, Sakuma M, Abe S, Shibasaki I, Toyoda S, Inoue T. Repeated in-stent restenosis despite aggressive lipid lowering by PCSK-9 inhibitor treatment: a case report. Tohoku J Exp Med 2021; 255(2): 123-126.

  2. Kono K, Abe S, Yamamoto M, Kayashima R, Kaneko K, Sakuma M, Toyoda S, Nakajima T, Inoue T. Vascular endothelial dysfunction and autonomic nervous hyperactivity among premenopausal women with cold-sensitivity constitution (Hiesho). Tohoku J Exp Med 2021; 253(1): 51-60.

  3. Masuyama T, Sakuma M, Waku R, Hirose S, Kitahara K, Naganuma J, Yazawa H, Toyoda S, Abe S, Nakajima T, Inoue T. Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study. Heart Vessels 2021; 36(4): 442-451.

  4. Suwa H, Koyabu Y, Adachi T, Kawai A, Kotani K, Toyoda S, Inoue T, Kato T. Usefulness of dual-axis rotational coronary angiography in primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction. Heart Vessels 2021; 36(5): 621-629.

  5. Toyoda S, Ida K, Kitagawa Y, Kamijima T, Saito I, Nishino S, Sakuma M, Ohki G, Naito S, Inoue T. Pacemaker treatment for apical hypertrophic cardiomyopathy in the setting of an apical ventricular aneurysm. JACC Case Rep 2021; 3(8): 1150-1155.

  6. Nakamura K, Takigawa M, Sasaki T, Minami K, Naito S. What are the post-ablation insular residual electrograms in the posterior left pulmonary veins electrically connected to? Indian Pacing Electrophysiol J 2021; 21(4): 241-244.

  7. Sakuma M, Nishino S, Nasuno T, Kageyama M, Tokura M, Sohma R, Inoue KI, Kanaya T, Obi S, Toyoda S, Abe S, Attizzani GF, Pereira GTR, Bezerra HG, Inoue T. Mobilization of progenitor cells and vessel healing after implantation of SYNERGY in acute coronary syndrome. Sci Rep 2021; 11(1): 17315.

  8. Nakamura K, Sasaki T, Minami K, Kishi S, Take Y, Naito S. An unusual location of the origin of an adenosine-sensitive atrial tachycardia: The lateral mitral annulus. J Cardiol Cases 2021; 24(2): 75-78.

  9. Hashimoto R, Numasawa Y, Yokokura S, Daigo K, Sakata S, Imaeda S, Hitomi Y, Sato K, Taruoka A, Haginiwa S, Kojima H, Tanaka M, Kuno T, Kodaira M. Prevalence of the Academic Research Consortium high bleeding risk criteria in patients undergoing endovascular therapy for peripheral artery disease in lower extremities. Heart Vessels 2021; 36(9): 1350-1358.

  10. Kitahara K, Sakuma M, Nishino S, Abe S, Inoue T, Toyoda S. Validity of flow-mediated dilation and reactive hyperemia index in assessing the risk of coronary artery disease based on the new definition by the Japan Society for Vascular Failure. Vasc Fail 2021; 5: 31-37.

一覧へ戻る